About Empirical Ventures
Empirical Ventures is a venture capital firm founded in 2024. It is primarily based out of Bristol, United Kingdom. As of Apr 2026, Empirical Ventures is an active investor, having invested in 15 companies, with 7 new investments in the last 12 months. It primarily invests in Seed round in United Kingdom based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Seed round of Fermtech A lot of funds co-invest with Empirical Ventures, with names like The FSE Group sharing a substantial percentage of its portfolio. Empirical Ventures has team of 12 people including 1 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed & Series A
Empirical Ventures' List of Top Investments
Empirical Ventures has a portfolio of 15 companies. Their most notable investments are in MintNeuro and HotGreen Solutions.Their portfolio spans across United Kingdom and China. They have invested in Life Sciences, High Tech, Enterprise Applications and 9 other sectors, across stages such as Seed, Series A stages. Here is the list of top investments by Empirical Ventures:
1. Signapse
Key facts about Signapse
- Founded Year: 2022
- Location: Guildford (United Kingdom)
- Valuation: $*****
- Stage: Seed
- Total Funding till date: $2.11M
- Employee Count: 19 as on Mar 31, 2025
- Investors: CEAS Investments, Soulmates Ventures and 14 Others
- Latest Funding Round: Seed, Apr 05, 2024, $*****
Manufacturer of electrotherapy devices for treating brain tumors. The company's flagship product is GRACE, an implanted device that delivers electric field therapy directly to the tumour resection margins where GBM recurrence takes place.
Key facts about QV Bioelectronics
- Founded Year: 2019
- Location: Manchester (United Kingdom)
- Stage: Series A
- Total Funding till date: $9.63M
- Employee Count: 6 as on Oct 31, 2021
- Investors: Catapult Ventures, NIH and 18 Others
- Latest Funding Round: Series A, Jan 21, 2026, $*****
3. BoobyBiome
Developer of research-backed microbiome solutions for infant health and well-being. The company formulates products based on breast milk microbiome research. It also facilitates breast milk donations to further investigate beneficial bacteria. The company advocates for the benefits of breast milk through accessible science.
Key facts about BoobyBiome
- Founded Year: 2019
- Location: London (United Kingdom)
- Stage: Seed
- Total Funding till date: $3.28M
- Employee Count: 3 as on Jul 31, 2021
- Investors: Evenlode Investment, XFactor Ventures and 12 Others
- Latest Funding Round: Seed, Sep 08, 2025, $*****
4. OSSTEC
Developer of regenerative orthopedic implants. The company specializes in bone healing technology and offers partial knee implants that stimulate long-term bone growth.
Key facts about OSSTEC
- Founded Year: 2021
- Location: London (United Kingdom)
- Valuation: $*****
- Stage: Series A
- Total Funding till date: $4.68M
- Employee Count: 3 as on Jul 31, 2022
- Investors: SFC Capital, Parkwalk and 9 Others
- Latest Funding Round: Series A, Apr 08, 2025, $*****
- Highlight: Editors' Pick

5. OutSee
Developer of an artificial intelligence engine for predictive genomics. The AI engine predicts disease and phenotype directly from a single genome. It uncovers biological mechanisms that drive and modulate disease, rather than matching known genetic associations. The technology can find additional results after other methods have been fully exploited. It predicts complex genetics, including multi-variant effects and mechanistically cooperative interactions. This allows grouping patients in ways that other methods cannot. The predictive approach works on small and large datasets.
Key facts about OutSee
- Location: United Kingdom
- Annual Revenue: £54K as on Sep 30, 2023
- Stage: Seed
- Total Funding till date: $5.79M
- Investors: Ahren, Empirical Ventures and 2 Others
- Latest Funding Round: Seed, Jan 13, 2026, $*****
Empirical Ventures' Year-on-Year Investment Trends
In 2025, it made 5 investments, while as of Apr 2026, it has made 4 investments in this year. Its most recent first time investment was in Fermtech and most recent follow-on round was in OutSee.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 3 | 1 | 4 |
2025 | 5 | 0 | 5 |
2024 | 7 | 0 | 7 |
Empirical Ventures' Investments by Stage
Empirical Ventures has made 12 investments in Seed stage with an average round size of $3.15M and 3 investments in Series A stage with an average round size of $6.67M.Stage of entry | No. of Investments |
|---|---|
Seed | 12 |
Series A | 3 |
Note: We have considered here, only first round of investments
Empirical Ventures' Investments by Sector
Empirical Ventures has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Sustainability Tech, Enterprise Applications and Environment Tech. Notably, it has invested in 11 Enterprise (B2B) companies, 11 Tech companies, 5 Tech hardware companies and at least 3 companies focusing on Software.Sector | No. of Investments |
|---|---|
Life Sciences | 6 |
High Tech | 4 |
Sustainability Tech | 3 |
Enterprise Applications | 2 |
Environment Tech | 2 |
Others | 12 |
Note: We have considered here, only first round of investments
Empirical Ventures' Investments by Geography
Empirical Ventures has made most investments in United Kingdom (14), followed by China where it has made 1 investment.Country | No. of Investments |
|---|---|
United Kingdom | 14 |
China | 1 |
Note: We have considered here, only first round of investments
Empirical Ventures' recent investments
Empirical Ventures has made 4 investments in 2026 so far. Fermtech and Orthofuse are the latest among them.Here are the most recent investments by Empirical Ventures:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Apr 08, 2026 | United Kingdom | Seed | 9852 | [+1] | |
Feb 12, 2026 | United Kingdom | Seed | 1985 | [+1] | |
Jan 21, 2026 | United Kingdom | Series A | 8593 | ||
Jan 13, 2026 | United Kingdom | Seed | 7173 | [+1] | |
Oct 21, 2025 | United Kingdom | Seed | 2117 |
Team profile of Empirical Ventures
Empirical Ventures has a team of 12 members including 1 Partner and 3 Principals located in United Kingdom. Empirical Ventures' team does not sit on the board of any company as of now.Here is a list of top team members in Empirical Ventures:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Bristol | - | ||
Principal | London | - | - | |
Principal | London | - | - | |
Principal | United Kingdom | - |
Co-investors of Empirical Ventures
Over the past 2 years, 78 investors have co-invested in Empirical Ventures's portfolio companies. This includes funds and angels.
- Invested before Empirical Ventures: Ukri, Science Angel Syndicate and 25 others have invested in rounds before Empirical Ventures. There are 4 companies where Ukri has invested before Empirical Ventures and 4 companies where Science Angel Syndicate has invested before Empirical Ventures.
- Top Co-investors of Empirical Ventures: 51 investors entered a company along with Empirical Ventures. These include investors like The FSE Group (2 companies).
Recent News related to Empirical Ventures
•
Empirical Ventures secures £10m to back ‘venture scientists’BusinessCloud•Mar 30, 2026•British Business Bank, empirical, Empirical Ventures
•
Orthofuse Raises £2.2M in Seed FundingFinSMEs•Feb 12, 2026•Orthofuse, Empirical Ventures, ACF Investors, Cambridge Angels
•
OutSee Closes £2.5M Seed Funding RoundFinSMEs•Jan 13, 2026•OutSee, Empirical Ventures, Kadmos Capital, Panacea Venture and 2 others
•
HotGreen Solutions Secures £1.2M To Scale Ultra-Efficient Industrial Heat PumpsStartup Rise EU•Oct 21, 2025•State of California, Coca-Cola Europacific Partners, Almanac Realty Investors, HotGreen Solutions and 1 other
•
British startup BoobyBiome’s €2.8 million raise for infant health with breast milk microbiome breakthroughEU-Startups•Sep 08, 2025•Empirical Ventures, Kayan Ventures, BoobyBiome, XFactor Ventures and 3 others
•
British BioTech EnsiliTech secures €5.2M to cut cold-chain costsEU-Startups•Aug 28, 2025•Empirical Ventures, EnsiliTech, Eos Advisory, Calculus Capital and 4 others
•
OutSee secures £1.8M to advance predictive genomics drug discovery with AI platform NomalyTech Funding News•Jun 24, 2025•OutSee, Ahren, Kadmos Capital, Empirical Ventures and 1 other
•
From London to New York OSSTEC Introduces 3D Printed Prostheticsstamparein3d.it•May 19, 2025•OSSTEC, Empirical Ventures
•
•
